Company intelligence / Profile preview

PainQx

New York City, New York, United Statespainqx.com ↗

Ownership: Private
Employees: ~20
Development stage: Preclinical

Overview

The ALGOS System has demonstrated the ability to objectively classify chronic pain states using EEG-derived biomarkers. It correlates with patient-reported Numeric Rating Scale scores and has been validated in multi-site human research studies funded by SBIR contracts from the Defense Health Agency and National Institute on Drug Abuse. Further algorithm refinement and clinical validation are ongoing.

Therapeutic areas: OtherNeurology
Modalities: DeviceNon-pharmacological therapy (objective pain assessment tool)Software as a Service (SaaS) platform
Industry: Physiological Monitoring

Partnerships

No major pharmaceutical or biotech partnerships disclosed. Collaborations include academic institutions such as NYU School of Medicine and government agencies like NIDA and DHA through SBIR grants.

Beyond the preview

Go deeper on PainQx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PainQx.

Explore the full profile